COA and purity

Acetate versus TFA salt: why the counter-ion matters

Where the counter-ion comes from, how TFA and acetate differ in net content, pH and cell toxicity, and which salt form Alphex supplies.

Synthetic peptides are supplied as salts, and the counter-ion is one of the least-noticed and most consequential details on a specification. It affects net peptide content, solubility, pH of the reconstituted solution, and, for cell-based work, whether the vehicle itself is toxic. This note explains where the counter-ion comes from, the difference between trifluoroacetate (TFA) and acetate salts, and why Alphex supplies acetate. All Alphex products are for laboratory and in-vitro research only.

Where the counter-ion comes from

Solid-phase peptide synthesis ends with cleavage of the peptide from the resin in strong acid, most commonly trifluoroacetic acid, and purification by reverse-phase HPLC using a mobile phase that contains 0.1% TFA. The peptide comes off the column as its TFA salt: every basic site (lysine and arginine side chains, histidine, the N-terminal amine) is paired with a trifluoroacetate ion. To supply an acetate salt, the manufacturer performs a salt exchange, passing the peptide through an ion-exchange step or repeated lyophilisation from dilute acetic acid to replace TFA with acetate. That step costs time and material, which is why TFA salts are the cheaper default across the market.

Why it matters

  • Net peptide content. TFA (113 g/mol) is nearly twice the mass of acetate (59 g/mol). For a peptide with three basic sites, the TFA salt carries about 160 g/mol more non-peptide mass than the acetate salt, which for a short peptide is a several-percent difference in net content. See net peptide content versus gross vial weight.
  • pH on reconstitution. TFA is a strong acid; a TFA-salt peptide dissolved in unbuffered water gives a more acidic solution than the acetate salt. For pH-sensitive assays this is a hidden variable.
  • Cell toxicity and assay interference. Residual TFA at the concentrations found in peptide stocks has been reported to affect cell proliferation and some enzyme assays. Acetate is a normal cellular metabolite and generally inert at those levels.
  • Analytical interference. TFA absorbs at low UV wavelengths and can distort baselines around 210-220 nm at high concentration; it also suppresses ionisation in electrospray mass spectrometry.
  • Solubility. Modest differences either way depending on the peptide; not usually decisive.

Which does Alphex supply?

Acetate. Every peptide in the catalogue (BPC-157, TB-500, Ipamorelin, GLP-3 (RT)) is supplied as the acetate salt; GHK-Cu is supplied as the copper complex, which has its own counter-ion chemistry. The salt form is stated on the specification table and the COA. If you are comparing prices between suppliers, check whether the cheaper listing is a TFA salt: like-for-like comparison needs the same salt form.

How to tell which salt you have

The COA should state it. If it does not, ion chromatography or fluorine NMR detects TFA directly, and a rough indication is the pH of a freshly reconstituted solution in pure water: TFA salts run noticeably more acidic. A supplier who cannot tell you the salt form has not asked their manufacturer a basic question.

Frequently asked questions

Is TFA salt "bad"?

Not inherently; it is the standard output of synthesis and fine for many purposes. It is a variable that should be known and stated, and for cell work acetate is the safer default.

Can I convert TFA to acetate myself?

In principle, by ion exchange or repeated lyophilisation from dilute acetic acid, but at research-vial scale the losses are large. Buy the salt form you need.

Does the salt form change the molecular weight on the COA?

The COA reports the peptide's own mass (the free peptide), which is what mass spectrometry measures; counter-ions dissociate in the electrospray. Molar calculations use that free-peptide mass. See molecular weight and molar calculations.

Alphex research peptides are supplied for laboratory and in-vitro research by qualified researchers only. They are not authorised for human or veterinary use.

Research use only. Alphex products are supplied exclusively for laboratory and in-vitro research by qualified researchers. They are not authorised for human or veterinary use, and nothing in this note is advice on any such use.

Published 28 April 2026. Alphex reviews research notes when the testing method, the catalogue or UK guidance changes.

Alphex Research Team

Alphex Limited, UK research peptide supplier

The Alphex research team writes and maintains these notes for UK laboratories buying research peptides. Every batch Alphex lists is verified by reverse-phase HPLC with a batch-matched Certificate of Analysis. Content covers laboratory and in-vitro research only.